Brief: Viracta Therapeutics Appoints Mark Rothera As President And CEO

Viracta Therapeutics

19/09/2022 13:39

Sept 19 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS ANNOUNCES CHIEF EXECUTIVE OFFICER
LEADERSHIP SUCCESSION TO DRIVE THE NEXT PHASE OF THE COMPANY'S
STRATEGIC DEVELOPMENT AND GROWTH
    * VIRACTA THERAPEUTICS ANNOUNCES CHIEF EXECUTIVE OFFICER
LEADERSHIP SUCCESSION TO DRIVE THE NEXT PHASE OF THE COMPANY'S
STRATEGIC DEVELOPMENT AND GROWTH
    * VIRACTA THERAPEUTICS INC - VIRACTA THERAPEUTICS' BOARD OF
DIRECTORS APPOINTS MARK ROTHERA AS PRESIDENT AND CHIEF EXECUTIVE
OFFICER
    * VIRACTA THERAPEUTICS INC - FOUNDING PRESIDENT AND CEO IVOR
ROYSTON, M.D. WILL CONTINUE TO SERVE AS A MEMBER OF VIRACTA'S
BOARD OF DIRECTORS

Source text for Eikon:  ID:nPn9bkMbca 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))